Kiora Pharmaceuticals Inc. (NASDAQ:KPRX) went up by 2.78% from its latest closing price compared to the recent 1-year high of $7.85. The company’s stock price has collected -7.63% of loss in the last five trading sessions. Press Release reported on 01/05/22 that Kiora Pharmaceuticals to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference
Is It Worth Investing in Kiora Pharmaceuticals Inc. (NASDAQ :KPRX) Right Now?
Plus, the 36-month beta value for KPRX is at 0.87. Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Kiora Pharmaceuticals Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $5.00, which is $8.87 above the current price. KPRX currently public float of 10.65M and currently shorts hold a 0.45% ratio of that float. Today, the average trading volume of KPRX was 3.05M shares.
KPRX’s Market Performance
KPRX stocks went down by -7.63% for the week, with a monthly drop of -28.84% and a quarterly performance of -53.36%, while its annual performance rate touched -84.94%. The volatility ratio for the week stands at 10.62% while the volatility levels for the past 30 days are set at 17.65% for Kiora Pharmaceuticals Inc.. The simple moving average for the period of the last 20 days is -6.54% for KPRX stocks with a simple moving average of -64.44% for the last 200 days.
KPRX Trading at -28.19% from the 50-Day Moving Average
After a stumble in the market that brought KPRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -87.76% of loss for the given period.
Volatility was left at 17.65%, however, over the last 30 days, the volatility rate increased by 10.62%, as shares sank -21.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -51.72% lower at present.
During the last 5 trading sessions, KPRX fell by -7.62%, which changed the moving average for the period of 200-days by -79.65% in comparison to the 20-day moving average, which settled at $1.0144. In addition, Kiora Pharmaceuticals Inc. saw -36.38% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for KPRX
Current profitability levels for the company are sitting at:
- -68104.78 for the present operating margin
The net margin for Kiora Pharmaceuticals Inc. stands at -67102.91. The total capital return value is set at -116.76, while invested capital returns managed to touch -116.13. Equity return is now at value -87.90, with -52.60 for asset returns.
Based on Kiora Pharmaceuticals Inc. (KPRX), the company’s capital structure generated 5.17 points at debt to equity in total, while total debt to capital is 4.92. Total debt to assets is 2.39, with long-term debt to equity ratio resting at 4.48. Finally, the long-term debt to capital ratio is 4.26.
When we switch over and look at the enterprise to sales, we see a ratio of 912.45, with the company’s debt to enterprise value settled at 0.02. The receivables turnover for the company is 0.25 and the total asset turnover is 0.00. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.02.